2022 annual financial data
Neuphoria Therapeutics 2022 Operating margin
Direct answer
Operating margin was -8,095.19%.
Operating income was -31,017,208 USD and net income was -22,939,197 USD.
Operating cash flow was -21,753,190 USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 383,156 USD
- Operating income
- -31,017,208 USD
- Net income
- -22,939,197 USD
- Operating cash flow
- -21,753,190 USD